Your browser doesn't support javascript.
loading
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.
Dercle, Laurent; Ammari, Samy; Seban, Romain-David; Schwartz, Lawrence H; Houot, Roch; Labaied, Nizar; Mokrane, Fatima-Zohra; Lazarovici, Julien; Danu, Alina; Marabelle, Aurélien; Ribrag, Vincent; Michot, Jean-Marie.
Afiliação
  • Dercle L; Gustave Roussy, Université Paris-Saclay, Inserm UMR1015, France; Gustave Roussy, Université Paris-Saclay, Département D'imagerie Médicale, Villejuif F-94805, France; Department of Radiology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, USA. Electronic address: la
  • Ammari S; Gustave Roussy, Université Paris-Saclay, Département D'imagerie Médicale, Villejuif F-94805, France.
  • Seban RD; Gustave Roussy, Université Paris-Saclay, Département D'imagerie Médicale, Villejuif F-94805, France.
  • Schwartz LH; Department of Radiology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, USA.
  • Houot R; CHU Rennes, Service Hematologie Clinique, Rennes, France.
  • Labaied N; Department of Pathology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.
  • Mokrane FZ; Department of Radiology, Toulouse University, France.
  • Lazarovici J; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.
  • Danu A; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.
  • Marabelle A; Gustave Roussy, Université Paris-Saclay, Inserm UMR1015, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.
  • Ribrag V; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.
  • Michot JM; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.
Eur J Cancer ; 91: 136-144, 2018 03.
Article em En | MEDLINE | ID: mdl-29360605
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article